BioSpace News Archive

Celltrion Healthcare presented new research at Digestive Disease Week® (DDW) 2018, that shows the efficacy and safety of the CT-P13 subcutaneous (SC) formulation is comparable to the CT-P13 intravenous (IV) formulation up to week 30 in patients with active Crohn’s disease (CD).

Chesapeake Urology Associates, LLC announced a partnership with Peninsula Urology Associates.

- New data are the first safety and efficacy data for an IL-23p19 monoclonal antibody for the treatment of moderate-to-severe ulcerative colitis - - Lilly will initiate a Phase 3 trial in moderate-to-severe ulcerative colitis this year -

Statement of Matthew L. Myers, President, Campaign for Tobacco-Free Kids

CheckedUp announced an initiative with the Foundation Fighting Blindness, the world’s leading private funder of inherited retinal disease research.

Kemwell Biopharma, a biologics contract development and manufacturing service provider, announced today that it has signed a contract to manufacture and supply drug substance using its state-of-the-art mammalian cell culture plant in India for Phase 3 clinical trials that will be conducted in the US by its customer for a BLA filing.

Healthcare Professionals Can Now Receive Alerts When Their Patient is Admitted to or Discharged from a Hospital Anywhere in the State Further Enhancing Care Coordination.

Zocdoc/Kelton Global survey reveals more than 80 percent of Atlantans are putting off their doctors’ visits; 54 percent of Atlantans say finding a new doctor is more frustrating than sitting in Atlanta traffic

The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal is proud to announce that it has received funding support from AbbVie

Pace International recently hosted its half-day Postharvest Academy